{"id":"https://openalex.org/W4205476563","doi":"https://doi.org/10.1182/blood.v124.21.808.808","title":"MUC1 As a Potential Therapeutic Target in Cutaneous T-Cell Lymphoma","display_name":"MUC1 As a Potential Therapeutic Target in Cutaneous T-Cell Lymphoma","publication_year":2014,"publication_date":"2014-12-06","ids":{"openalex":"https://openalex.org/W4205476563","doi":"https://doi.org/10.1182/blood.v124.21.808.808"},"language":"en","primary_location":{"id":"doi:10.1182/blood.v124.21.808.808","doi":"https://doi.org/10.1182/blood.v124.21.808.808","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v124.21.808.808","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5080982554","display_name":"Salvia Sanjay Jain","orcid":"https://orcid.org/0000-0003-1566-9308","observed_orcids":["https://orcid.org/0000-0003-1566-9308"]},"institutions":[{"id":"https://openalex.org/I1316535847","display_name":"Beth Israel Deaconess Medical Center","ror":"https://ror.org/04drvxt59","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316535847"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Salvia Jain","raw_affiliation_strings":["Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I1316535847","https://openalex.org/I136199984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109389698","display_name":"Maroof Alam","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Maroof Alam","raw_affiliation_strings":["Dana Farber Cancer Institute, Harvard Medical School, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana Farber Cancer Institute, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049901416","display_name":"Hasan N. Rajabi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hasan Rajabi","raw_affiliation_strings":["Dana Farber Cancer Institute, Harvard Medical School, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana Farber Cancer Institute, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102834605","display_name":"Dina Stroopinsky","orcid":"https://orcid.org/0000-0002-9749-2704","observed_orcids":["https://orcid.org/0000-0002-9749-2704"]},"institutions":[{"id":"https://openalex.org/I1316535847","display_name":"Beth Israel Deaconess Medical Center","ror":"https://ror.org/04drvxt59","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316535847"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Dina Stroopinsky","raw_affiliation_strings":["Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I1316535847","https://openalex.org/I136199984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100451096","display_name":"Li Yin","orcid":"https://orcid.org/0000-0001-5280-0075","observed_orcids":["https://orcid.org/0000-0001-5280-0075"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Li Yin","raw_affiliation_strings":["Dana Farber Cancer Institute, Harvard Medical School, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana Farber Cancer Institute, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054346063","display_name":"Jacalyn M. Rosenblatt","orcid":"https://orcid.org/0000-0001-5582-8161","observed_orcids":["https://orcid.org/0000-0001-5582-8161"]},"institutions":[{"id":"https://openalex.org/I1316535847","display_name":"Beth Israel Deaconess Medical Center","ror":"https://ror.org/04drvxt59","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316535847"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jacalyn Rosenblatt","raw_affiliation_strings":["Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I1316535847","https://openalex.org/I136199984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112223435","display_name":"Kristen Anna Palmer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1316535847","display_name":"Beth Israel Deaconess Medical Center","ror":"https://ror.org/04drvxt59","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316535847"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kristen A Palmer","raw_affiliation_strings":["Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I1316535847","https://openalex.org/I136199984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049677713","display_name":"Maxwell Douglas Coll","orcid":"https://orcid.org/0000-0002-2507-7587","observed_orcids":["https://orcid.org/0000-0002-2507-7587"]},"institutions":[{"id":"https://openalex.org/I1316535847","display_name":"Beth Israel Deaconess Medical Center","ror":"https://ror.org/04drvxt59","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316535847"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Maxwell Douglas Coll","raw_affiliation_strings":["Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I1316535847","https://openalex.org/I136199984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091120493","display_name":"Athalia Rachel Pyzer","orcid":"https://orcid.org/0000-0002-0506-1887","observed_orcids":["https://orcid.org/0000-0002-0506-1887"]},"institutions":[{"id":"https://openalex.org/I1316535847","display_name":"Beth Israel Deaconess Medical Center","ror":"https://ror.org/04drvxt59","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316535847"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Athalia Rachel Pyzer","raw_affiliation_strings":["Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I1316535847","https://openalex.org/I136199984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063723398","display_name":"Katarina Luptakova","orcid":"https://orcid.org/0009-0005-2745-2220","observed_orcids":["https://orcid.org/0009-0005-2745-2220"]},"institutions":[{"id":"https://openalex.org/I1316535847","display_name":"Beth Israel Deaconess Medical Center","ror":"https://ror.org/04drvxt59","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316535847"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Katarina Luptakova","raw_affiliation_strings":["Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I1316535847","https://openalex.org/I136199984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016770040","display_name":"Jon E. Arnason","orcid":"https://orcid.org/0000-0001-9038-7277","observed_orcids":["https://orcid.org/0000-0001-9038-7277"]},"institutions":[{"id":"https://openalex.org/I1316535847","display_name":"Beth Israel Deaconess Medical Center","ror":"https://ror.org/04drvxt59","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316535847"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jon Arnason","raw_affiliation_strings":["Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I1316535847","https://openalex.org/I136199984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028590331","display_name":"Robin Joyce","orcid":"https://orcid.org/0000-0002-7251-8082","observed_orcids":["https://orcid.org/0000-0002-7251-8082"]},"institutions":[{"id":"https://openalex.org/I1316535847","display_name":"Beth Israel Deaconess Medical Center","ror":"https://ror.org/04drvxt59","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316535847"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robin Joyce","raw_affiliation_strings":["Beth Israel Deaconess Medical Center, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Beth Israel Deaconess Medical Center, Boston, MA","institution_ids":["https://openalex.org/I1316535847"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091223719","display_name":"Michal Bar\u2010Natan","orcid":"https://orcid.org/0000-0002-2111-1231","observed_orcids":["https://orcid.org/0000-0002-2111-1231"]},"institutions":[{"id":"https://openalex.org/I1316535847","display_name":"Beth Israel Deaconess Medical Center","ror":"https://ror.org/04drvxt59","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316535847"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michal Bar-Natan","raw_affiliation_strings":["Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I1316535847","https://openalex.org/I136199984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014663195","display_name":"Poorvi Somaiya","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1316535847","display_name":"Beth Israel Deaconess Medical Center","ror":"https://ror.org/04drvxt59","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316535847"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Poorvi Somaiya","raw_affiliation_strings":["Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I1316535847","https://openalex.org/I136199984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018201884","display_name":"Rachael A. Clark","orcid":"https://orcid.org/0000-0002-6105-5764","observed_orcids":["https://orcid.org/0000-0002-6105-5764","https://orcid.org/0000-0002-2725-3257"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rachael A Clark","raw_affiliation_strings":["Brigham and Women's Hospital, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Brigham and Women's Hospital, Boston, MA","institution_ids":["https://openalex.org/I1283280774"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091128223","display_name":"Thomas Seth Kupper","orcid":"https://orcid.org/0000-0002-4229-2916","observed_orcids":["https://orcid.org/0000-0002-4229-2916"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Thomas S. Kupper","raw_affiliation_strings":["Brigham & Women's Hosp., Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Brigham & Women's Hosp., Boston, MA","institution_ids":["https://openalex.org/I1283280774"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067054634","display_name":"Donald W. Kufe","orcid":"https://orcid.org/0000-0001-5743-8888","observed_orcids":["https://orcid.org/0000-0001-5743-8888"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Donald Kufe","raw_affiliation_strings":["Dana Farber Cancer Institute, Harvard Medical School, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana Farber Cancer Institute, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5052641327","display_name":"David Avigan","orcid":"https://orcid.org/0000-0003-4624-6017","observed_orcids":["https://orcid.org/0000-0003-4624-6017"]},"institutions":[{"id":"https://openalex.org/I1316535847","display_name":"Beth Israel Deaconess Medical Center","ror":"https://ror.org/04drvxt59","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316535847"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David Avigan","raw_affiliation_strings":["Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I1316535847","https://openalex.org/I136199984"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.48233451,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"124","issue":"21","first_page":"808","last_page":"808"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11811","display_name":"Cutaneous lymphoproliferative disorders research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11811","display_name":"Cutaneous lymphoproliferative disorders research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12159","display_name":"T-cell and Retrovirus Studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/muc1","display_name":"MUC1","score":0.9860000014305115},{"id":"https://openalex.org/keywords/cutaneous-t-cell-lymphoma","display_name":"cutaneous T-cell lymphoma","score":0.968999981880188},{"id":"https://openalex.org/keywords/mycosis-fungoides","display_name":"mycosis fungoides","score":0.9950000047683716},{"id":"https://openalex.org/keywords/sezary-syndrome","display_name":"S\u00e9zary syndrome","score":0.8889999985694885},{"id":"https://openalex.org/keywords/therapeutic-target","display_name":"therapeutic target","score":0.7459999918937683},{"id":"https://openalex.org/keywords/receptor-dimerization","display_name":"receptor dimerization","score":0.6729999780654907},{"id":"https://openalex.org/keywords/cell-growth-inhibition","display_name":"cell growth inhibition","score":0.628000020980835},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.652999997138977}],"concepts":[{"id":"https://openalex.org/C2777756187","wikidata":"https://www.wikidata.org/wiki/Q1891209","display_name":"Mycosis fungoides","level":3,"score":0.8422297239303589},{"id":"https://openalex.org/C2777421810","wikidata":"https://www.wikidata.org/wiki/Q21145188","display_name":"MUC1","level":3,"score":0.5624785423278809},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.5544042587280273},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5238494873046875},{"id":"https://openalex.org/C553184892","wikidata":"https://www.wikidata.org/wiki/Q1141429","display_name":"Flow cytometry","level":2,"score":0.5196093916893005},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.49817323684692383},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.48094242811203003},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.47869113087654114},{"id":"https://openalex.org/C2776780870","wikidata":"https://www.wikidata.org/wiki/Q5196687","display_name":"Cutaneous T-cell lymphoma","level":4,"score":0.4603092670440674},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.45920923352241516},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3353053629398346},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.20102673768997192},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.10639572143554688},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.06170499324798584}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood.v124.21.808.808","doi":"https://doi.org/10.1182/blood.v124.21.808.808","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v124.21.808.808","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2115824726","https://openalex.org/W7098258624","https://openalex.org/W7099217665","https://openalex.org/W3035884640","https://openalex.org/W3205314012","https://openalex.org/W4230574050","https://openalex.org/W2131233619","https://openalex.org/W7096365401","https://openalex.org/W1987958787","https://openalex.org/W3145159330"],"abstract_inverted_index":{"Abstract":[0],"Introduction:":[1],"MUC1":[2,27,48,73,135,151,198],"is":[3,7,615,647],"an":[4,208,411,674],"oncoprotein":[5],"that":[6,47,234,245,461,623,658],"aberrantly":[8],"expressed":[9,76,131,617],"in":[10,28,52,203,265,280,291,325,353,413,428,455,468,479,487,531,544,547,565,573,583,593,601,618,637,640,644,645,655,661,679],"many":[11],"epithelial":[12],"tumors":[13],"and":[14,20,23,59,71,86,89,96,104,155,160,225,240,243,271,277,294,304,323,330,393,401,415,438,495,533,622,639,653],"hematologic":[15],"malignancies,":[16],"conferring":[17],"cell":[18,80,92,116,267,296,327,620],"growth":[19,251],"survival.":[21],"Expression":[22],"functional":[24],"significance":[25],"of":[26,55,68,134,149,181,210,274,283,316,339,347,349,356,371,383,391,398,418,440,472,484,518,580,608,625,651,670],"cutaneous":[29],"T-cell":[30,140],"lymphoma":[31,114],"(CTCL)":[32],"has":[33],"not":[34],"been":[35],"previously":[36],"characterized.":[37],"In":[38,111],"the":[39,44,53,64,78,90,175,189,211,246,281,384,432,453,459,516,556,566,574,584,594,602,626,631,668],"present":[40],"study,":[41],"we":[42],"evaluated":[43,478],"potential":[45,669],"role":[46],"mediated":[49,424,465],"signaling":[50],"plays":[51],"pathogenesis":[54],"Mycosis":[56],"Fungoides":[57],"(MF)":[58],"Sezary":[60],"Syndrome":[61],"cells":[62,164,242,279,403,499],"(SS),":[63],"2":[65,326,488],"common":[66],"subtypes":[67],"CTCL.":[69,204,680],"Methods":[70],"results:":[72],"was":[74,165,183,230,319,365,408,436,464,477,512,562,590],"strongly":[75],"on":[77,153,158],"SS":[79],"lines":[81,117,268,328],"HuT-78":[82,494,532,557],"(60%),":[83],"H9":[84,270,276,402],"(77%)":[85],"SeAx":[87],"(59%)":[88],"MF":[91],"lines,":[93,621],"Myla":[94,278,331,400,498,534,585],"(94%)":[95],"HuT-102":[97],"(87%)":[98],"when":[99,333],"incubated":[100],"with":[101,169,335,410,431,446,450,510,550,630,649],"anti-MUC1":[102],"antibody":[103,171],"analyzed":[105,380],"by":[106,192,238,252,301,308,314,321,395,426,466,527],"flow":[107],"cytometry":[108],"(FCM)":[109],".":[110],"contrast,":[112],"B-cell":[113],"(BCL)":[115],"(Val,":[118],"K422,":[119],"Toledo,":[120],"SU-DHL-2,":[121],"OCI-Ly7,":[122],"OCI-Ly8,":[123],"SU-DHL-5,":[124],"SU-DHL-8,":[125],"OCI-Ly3,":[126],"RCK8,":[127],"Ramos,":[128],"Daudi,":[129],"JVM-2)":[130],"minimal":[132,156],"levels":[133,439],"(0-7%),":[136],"as":[137,199,299,312],"did":[138],"circulating":[139,162],"populations":[141],"isolated":[142],"from":[143,259],"healthy":[144],"controls":[145],"(0-3%).":[146],"The":[147,178,470,611],"finding":[148],"high":[150],"expression":[152,157,179,382],"CTCL":[154,619],"BCL":[159],"normal":[161],"T":[163],"confirmed":[166],"byimmunoblotting":[167],"(IB)":[168],"another":[170],"directed":[172],"against":[173],"MUC1-C,":[174],"oncogenic":[176,627],"subunit.":[177],"profile":[180],"MUC1-C":[182,212,219,614,628,643,659,671],"found":[184],"to":[185,249,262,375,404,474,553,672],"be":[186,673],"similar":[187],"at":[188,337,515],"mRNA":[190],"level":[191,355],"RT-PCR":[193],"analysis.":[194],"We":[195,205],"subsequently":[196],"examined":[197],"a":[200,360,387,482,540,578,606],"therapeutic":[201,677],"target":[202,678],"have":[206],"developed":[207],"inhibitor":[209,633],"receptor":[213],"subunit,":[214],"designated":[215],"GO-203,":[216,427],"which":[217],"blocks":[218],"dimerization":[220],"necessary":[221],"for":[222,288,342,381,406,521],"nuclear":[223],"translocation":[224],"downstream":[226],"signaling.":[227],"Growth":[228],"inhibition":[229],"determined":[231,300],"using":[232,367],"CellTiter-Glo":[233],"measures":[235],"ATP":[236],"produced":[237],"live":[239],"proliferating":[241],"demonstrated":[244,539],"concentration":[247,287,338],"required":[248],"inhibit":[250],"50%":[253],"(IC50)":[254],"following":[255],"72-hour":[256],"exposure":[257],"ranged":[258],"3":[260,522],"uM":[261,264,285,341],"3.5":[263],"most":[266],"(HuT-78,":[269],"Myla).":[272],"Culture":[273],"HuT-78,":[275],"presence":[282],"5":[284,340],"GO-203":[286,336,350,405,473,511,551,567,595,634],"72-hours":[289,407],"resulted":[290],"70,":[292],"80":[293],"90%":[295],"death":[297],"respectively":[298],"Annexin":[302],"V":[303],"propidium":[305],"iodide":[306],"staining":[307],"FCM.":[309],"Cell":[310,377],"proliferation,":[311],"assessed":[313],"incorporation":[315],"tritiated":[317],"thymidine,":[318],"inhibited":[320],"70%":[322],"80%":[324],"(HuT-78":[329],"respectively)":[332],"treated":[334,549,568,596],"72-hours.":[343],"To":[344,421],"determine":[345],"mechanism":[346],"action":[348],"induced":[351],"apoptosis":[352,394,425,636],"vitro,":[354],"hydrogen":[357],"peroxide":[358],"(H2O2),":[359],"reactive":[361],"oxygen":[362],"species":[363],"(ROS)":[364],"measured":[366,443],"FCM":[368],"based":[369],"conversion":[370],"carboxy-2\u20327\u2032":[372],"dichlorodihydrofluorescein":[373],"diacetate":[374],"2\u20327\u2032-dichlorodihydrofluorescein.":[376],"lysates":[378],"were":[379,442,500],"protein":[385],"TIGAR,":[386],"fructose-2-6-bisphosphatase":[388],"p53-inducible":[389],"regulator":[390],"glycolysis":[392],"IB.":[396],"Exposure":[397],"Hut-78,":[399],"associated":[409,648],"increase":[412],"ROS":[414,423],"down":[416],"regulation":[417],"TIGAR":[419,456,652],"expression.":[420],"confirm":[422],"vitro":[429,638,646],"treatment":[430],"antioxidant":[433],"N-acetylcysteine":[434],"(NAC)":[435],"performed":[437],"H2O2":[441],"including":[444],"IB":[445],"anti-TIGAR":[447],"antibody.":[448],"Treatment":[449,509],"NAC":[451],"blocked":[452],"decreases":[454],"levels,":[457],"supporting":[458],"hypothesis":[460],"this":[462],"response":[463],"increases":[467,654],"ROS.":[469],"ability":[471],"eradicate":[475],"disease":[476],"vivo":[480],"across":[481],"spectrum":[483],"tumor":[485,545,560,588],"volumes":[486],"xenograft":[489,535,586],"mouse":[490,537],"models.":[491],"Five":[492],"million":[493,497],"2.5":[496],"injected":[501],"subcutaneously":[502],"(SC)":[503],"into":[504],"NOD-SCID":[505],"IL2Rgammanull":[506],"(NSG)":[507],"mice.":[508],"administered":[513],"daily":[514],"dose":[517],"14mg/kg":[519],"SC":[520],"weeks.":[523],"Tumor":[524],"volumetric":[525],"analysis":[526],"three-dimensional":[528],"ultrasound":[529],"(3D-US)":[530],"NSG":[536],"models":[538],"statistically":[541],"significant":[542],"decrease":[543],"volume":[546,561,589],"mice":[548],"compared":[552],"control":[554,575,603],"(In":[555],"xenograft,":[558],"average":[559,587],"707":[563],"mm3":[564,572,592,600],"arm":[569,576,597,604],"versus":[570,598],"1171":[571],"rendering":[577,605],"p-value":[579,607],"0.0029;":[581],"whereas":[582],"184":[591],"1080":[599],"0.0001).":[609],"Conclusion:":[610],"data":[612],"demonstratesthat":[613],"highly":[616],"blockade":[624],"subunit":[629],"peptide":[632],"induces":[635],"vivo.":[641],"Targeting":[642],"down-regulation":[650],"ROS,":[656],"indicating":[657],"functions":[660],"maintaining":[662],"redox":[663],"balance.":[664],"Our":[665],"results":[666],"highlight":[667],"exciting":[675],"new":[676],"Disclosures":[681],"Kufe:":[682],"Genus":[683],"Oncology:":[684],"Consultancy,":[685],"Equity":[686],"Ownership.":[687]},"counts_by_year":[],"updated_date":"2026-10-08T09:06:37.294493","created_date":"2022-01-26T00:00:00"}